# A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing

> **NCT07214272** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Bausch Health Americas, Inc.** · enrollment: 49 (actual)

## Conditions studied

- Skin Resurfacing

## Interventions

- **DEVICE:** Fraxel® FTX Laser System

## Key facts

- **NCT ID:** NCT07214272
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-17
- **Primary completion:** 2026-05
- **Final completion:** 2026-09
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07214272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07214272, "A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07214272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*